Koninklijke DSM N.V.

OTC: KDSKF

GO
/marketstate/country/us

Market open

 --Quotes are delayed by 20 min

Aug 4, 2022, 1:22 p.m.

/zigman2/quotes/206247551/composite

$

148.75

Change

-1.90 -1.26%

Volume

Volume 0

Quotes are delayed by 20 min

/zigman2/quotes/206247551/composite

Previous close

$ 150.65

$ 148.75

Change

-1.90 -1.26%

Day low

Day high

$148.75

$151.75

Open

52 week low

52 week high

$138.50

$232.50

Open

Company Description

Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal...

Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal feed, food and beverage, pharmaceuticals, infant nutrition, dietary supplements, and personal care. The Materials segment deals with specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. The Innovation Center segment focuses on innovation and the growth of DSM's existing core business through adjacent technologies. The Corporate Activities segment consists of operating and service activities as well as other several costs. The company was founded in 1902 and is headquartered in Herleen, the Netherlands.

Valuation

P/E Current

14.70

P/E Ratio (without extraordinary items)

20.47

Price to Sales Ratio

3.73

Price to Book Ratio

3.70

Price to Cash Flow Ratio

24.90

Enterprise Value to EBITDA

14.14

Enterprise Value to Sales

2.87

Total Debt to Enterprise Value

0.09

Efficiency

Revenue/Employee

430,939.00

Income Per Employee

50,847.00

Receivables Turnover

5.80

Total Asset Turnover

0.60

Liquidity

Current Ratio

2.52

Quick Ratio

1.58

Cash Ratio

0.84

Profitability

Gross Margin

34.38

Operating Margin

12.46

Pretax Margin

9.94

Net Margin

11.80

Return on Assets

7.10

Return on Equity

12.99

Return on Total Capital

9.73

Return on Invested Capital

9.37

Capital Structure

Total Debt to Total Equity

33.43

Total Debt to Total Capital

24.92

Total Debt to Total Assets

19.32

Long-Term Debt to Equity

32.31

Long-Term Debt to Total Capital

24.08

Officers and Executives

Name Age Officer Since Title
Mr. Dimitri de Vreeze 54 2013 Co-Chief Executive Officer & COO
Ms. Géraldine Matchett 49 2014 Co-Chief Executive Officer & CFO
Mr. Timothy A. Tolhurst 57 - Chief Purchasing Officer & EVP
Mr. Fokko Wientjes - 1988 Director-Corporate Sustainable Development
Ms. Wendy Cremers - - Project Manager-Recruitment

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/04/2021 John Ramsay
11   Acquisition at $149.05 per share. 1,639
06/04/2021 John Ramsay
5   Acquisition at $149.05 per share. 745
03/31/2021 Dimitri de Vreeze
1,850   Acquisition at $147.4 per share. 272,690
03/31/2021 Dimitri de Vreeze
1,850   Acquisition at $147.4 per share. 272,690
03/31/2021 Géraldine Matchett
1,850   Acquisition at $147.4 per share. 272,690
03/31/2021 Géraldine Matchett
1,850   Acquisition at $147.4 per share. 272,690
03/31/2021 Dimitri de Vreeze
10,962   Award at $0 per share. 0
03/31/2021 Dimitri de Vreeze
10,962   Award at $0 per share. 0
03/31/2021 Géraldine Matchett
10,962   Award at $0 per share. 0
03/31/2021 Géraldine Matchett
10,962   Award at $0 per share. 0
03/31/2021 Dimitri de Vreeze
5,167   Disposition at $145.12 per share. 749,835
03/31/2021 Dimitri de Vreeze
5,167   Disposition at $145.12 per share. 749,835
03/31/2021 Géraldine Matchett
4,358   Disposition at $145.12 per share. 632,432
03/31/2021 Géraldine Matchett
4,358   Disposition at $145.12 per share. 632,432
11/30/2020 Dimitri de Vreeze
6,000   Acquisition at $48.91 per share. 293,460
11/30/2020 Dimitri de Vreeze
6,000   Acquisition at $48.91 per share. 293,460
11/30/2020 Dimitri de Vreeze
6,000   Disposition at $137.67 per share. 826,020
11/30/2020 Dimitri de Vreeze
6,000   Disposition at $137.67 per share. 826,020
05/08/2020 Dimitri de Vreeze
12,000   Disposition at $114.2 per share. 1,370,400
05/08/2020 Dimitri de Vreeze
12,000   Disposition at $114.2 per share. 1,370,400
05/08/2020 Dimitri de Vreeze
12,000   Derivative/Non-derivative trans. at $40.9 per share. 490,800
05/08/2020 Dimitri de Vreeze
12,000   Derivative/Non-derivative trans. at $40.9 per share. 490,800
05/08/2020 Thomas Leysen
5,035   Award at $0 per share. 0
03/31/2020 Feike Sijbesma
27,171   Derivative/Non-derivative trans. at $0 per share. 0
03/31/2020 Dimitri de Vreeze
1,632   Derivative/Non-derivative trans. at $105 per share. 171,360
03/31/2020 Dimitri de Vreeze
17,666   Derivative/Non-derivative trans. at $0 per share. 0
03/31/2020 Dimitri de Vreeze
1,632   Derivative/Non-derivative trans. at $105 per share. 171,360
03/31/2020 Dimitri de Vreeze
17,666   Derivative/Non-derivative trans. at $0 per share. 0
03/31/2020 Géraldine Matchett
17,666   Derivative/Non-derivative trans. at $0 per share. 0
03/31/2020 Géraldine Matchett
17,666   Derivative/Non-derivative trans. at $0 per share. 0
03/31/2020 Feike Sijbesma
2,578   Acquisition at $105 per share. 270,690
03/31/2020 Géraldine Matchett
1,558   Acquisition at $105 per share. 163,590
03/31/2020 Géraldine Matchett
1,558   Acquisition at $105 per share. 163,590
03/31/2020 Feike Sijbesma
12,134   Disposition at $102.15 per share. 1,239,488
03/31/2020 Dimitri de Vreeze
8,326   Disposition at $102.15 per share. 850,500
03/31/2020 Dimitri de Vreeze
8,326   Disposition at $102.15 per share. 850,500
03/31/2020 Géraldine Matchett
6,307   Disposition at $102.15 per share. 644,260
03/31/2020 Géraldine Matchett
6,307   Disposition at $102.15 per share. 644,260
03/31/2019 Feike Sijbesma
3,872   Acquisition at $97.74 per share. 378,449
03/31/2019 Géraldine Matchett
2,552   Acquisition at $97.74 per share. 249,432
03/31/2019 Géraldine Matchett
2,552   Acquisition at $97.74 per share. 249,432
03/31/2019 Feike Sijbesma
36,350   Derivative/Non-derivative trans. at $0 per share. 0
03/31/2019 Géraldine Matchett
24,006   Derivative/Non-derivative trans. at $0 per share. 0
03/31/2019 Géraldine Matchett
24,006   Derivative/Non-derivative trans. at $0 per share. 0
03/31/2019 Feike Sijbesma
17,073   Disposition at $98.82 per share. 1,687,153
03/31/2019 Géraldine Matchett
8,013   Disposition at $98.82 per share. 791,844
03/31/2019 Géraldine Matchett
8,013   Disposition at $98.82 per share. 791,844
02/28/2019 Dimitri de Vreeze
18,000   Disposition at $94.44 per share. 1,699,920
02/28/2019 Dimitri de Vreeze
18,000   Disposition at $94.44 per share. 1,699,920
02/28/2019 Dimitri de Vreeze
18,000   Derivative/Non-derivative trans. at $46.2 per share. 831,600
02/28/2019 Dimitri de Vreeze
18,000   Derivative/Non-derivative trans. at $46.2 per share. 831,600
/news/latest/company/us/kdskf

MarketWatch News on KDSKF

  1. Updates, advisories and surprises

    5:01 p.m. Nov. 1, 2011

    - MarketWatch

  2. Royal DSM 3rd-quarter net doubled, sales up 5%

    3:44 a.m. Nov. 1, 2011

    - Robert Daniel

  3. Stocks to watch for Tuesday

    6:12 a.m. Dec. 21, 2010

    - Sue Chang

  4. Martek agrees to $31.50-share bid from Royal DSM

    2:38 a.m. Dec. 21, 2010

    - Robert Daniel

  5. Martek shares closed Monday at $23.36

    2:24 a.m. Dec. 21, 2010

    - Robert Daniel

  6. Royal DSM to pay total $1.09B for Martek

    2:25 a.m. Dec. 21, 2010

    - Robert Daniel

  7. Royal DSM to pay $31.50-shr for Martek Biosciences

    2:23 a.m. Dec. 21, 2010

    - Robert Daniel

  8. Martek Biosciences to be bought by Royal DSM

    2:23 a.m. Dec. 21, 2010

    - Robert Daniel

/news/nonmarketwatch/company/us/kdskf

Other News on KDSKF

  1. DSM NV: Staying Resilient Through The Downcycle

    6:52 p.m. May 10, 2022

    - Seeking Alpha

  2. JTD: Multi-Asset Fund Set To Get Larger, Some Appeal Here

    12:27 p.m. June 25, 2021

    - Seeking Alpha

  3. Koninklijke DSM NV 2018 Q1 - Results - Earnings Call Slides

    1:49 p.m. May 8, 2018

    - Seeking Alpha

  4. Koninklijke DSM NV 2017 Q4 - Results - Earnings Call Slides

    2:57 p.m. Feb. 14, 2018

    - Seeking Alpha

  5. Koninklijke DSM NV 2017 Q3 - Results - Earnings Call Slides

    1:51 p.m. Nov. 5, 2017

    - Seeking Alpha

  6. Loading more headlines...

At a Glance

Koninklijke DSM NV

Het Overloon 1

Heerlen, Limburg 6411 TE

Phone

31 455788111

Industry

Chemicals

Sector

Basic Materials/Resources

Fiscal Year-end

12/2022

Revenue

$9.20B

Net Income

$1.09B

2021 Sales Growth

13.5%

Employees

21,358

/news/pressrelease/company/us/kdskf

Press Releases on KDSKF

  1. Loading more headlines...
Link to MarketWatch's Slice.